Sharing Interests with Shareholders Through Performance-Linked Compensation and Restricted Stock
First written in FY2019. 16 of 18 entries say "Advanced", first in FY2020-Q2. Latest entry: 2026-08-04.
87 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The achievement rate for the company-wide financial performance indicators was 101.4%.」
For performance-linked compensation, revenue, operating profit, ROIC and ROE were used as company-wide financial indicators, and the achievement rate for the company-wide financial performance indicators was 101.4% for the year. The evaluation coefficient for the future corporate value target, ranging from 0% to 120%, also continued to apply. - 2026-06-02RestatedGeneral Meetings of Shareholders
「We determine officer compensation after considering an appropriate balance among fixed compensation, performance-linked compensation (bonuses) and restricted stock, so that directors responsible for business execution are appropriately motivated to improve corporate value over the medium to long term while taking appropriate risks.」
The Company continued to disclose its officer compensation policy, including performance-linked compensation and share-based compensation. - FY2026-H1AdvancedAnnual report
「No. 13 Stock Acquisition Rights Date of resolution 17 July 2025 Number of stock acquisition rights (units) 5,233 Categories and number of grantees (people) Executive officers 12 Responsible officer 1 Fellows 2 Number of shares underlying the stock acquisition rights (shares) 41,864 Exercise period for stock acquisition rights From 5 August 2025 To 4 August 2055」
No. 13 stock acquisition rights were granted to 12 executive officers, 1 responsible officer and 2 fellows. The grant comprised 5,233 stock acquisition rights and 41,864 underlying shares, with an exercise period from 5 August 2025 to 4 August 2055. - FY2025-H1AdvancedAnnual report
「No. 12 Stock Acquisition Rights Date of resolution 11 July 2024 Number of stock acquisition rights (units) 4,048 Categories and number of grantees (people) Executive officers 12 Fellows 2 Number of shares underlying the stock acquisition rights (shares) 32,384 Exercise period for stock acquisition rights From 3 August 2024 To 2 August 2054」
No. 12 stock acquisition rights were granted to 12 executive officers and 2 fellows. The grant comprised 4,048 stock acquisition rights and 32,384 underlying shares, with an exercise period from 3 August 2024 to 2 August 2054. - FY2024AdvancedAnnual report
「From FY2023, the Company began applying a future corporate value target, an indicator that contributes to enhancing corporate value over the medium to long term. Evaluation coefficients ranging from 0% to 120% are scheduled to be applied according to the level of achievement at the end of the period.」
The future corporate value target was incorporated into performance evaluations for executive compensation, and the Company began applying evaluation coefficients ranging from 0% to 120% according to the level of achievement. Achievement rates disclosed for the company-wide performance indicators were 108% for revenue, 106% for operating profit, 102% for ROIC and 103% for ROE. - FY2024-Q2AdvancedAnnual report
「No. 11 Stock Acquisition Rights; number of stock acquisition rights (units): 5,092; categories and number of grantees (people): executive officers 9, fellows 3, senior employees of group companies 2; number of shares underlying the stock acquisition rights (shares): 20,368; exercise period: from 3 August 2023 to 2 August 2053.」
No. 11 stock acquisition rights were granted to 9 executive officers, 3 fellows and 2 senior employees of group companies. The grant comprised 5,092 stock acquisition rights and 20,368 underlying shares, with an exercise period from 3 August 2023 to 2 August 2053. - FY2023AdvancedAnnual report
「From FY2023, the Company began applying a future corporate value target, an indicator that contributes to enhancing corporate value over the medium to long term. Evaluation coefficients ranging from 0% to 120% are scheduled to be applied according to the level of achievement at the end of the period.」
For performance-linked compensation, a future corporate value target was introduced from FY2023 in addition to revenue, operating profit, ROIC and ROE, among other measures, establishing a mechanism for reflecting the level of achievement in compensation. - FY2023-Q2AdvancedAnnual report
「2022 Stock Options; date of resolution: 22 June 2022; number of stock acquisition rights (units): 4,628; categories and number of grantees (people): executive officers 9, fellows 3; number of shares underlying the stock acquisition rights (shares): 18,512; exercise period: from 16 July 2022 to 15 July 2052.」
As 2022 stock options, 4,628 stock acquisition rights and 18,512 underlying shares were granted to 9 executive officers and 3 fellows. - FY2022AdvancedAnnual report
「During the current consolidated fiscal year, 46,995 shares were granted under the restricted stock compensation plan. The restriction period is 30 years.」
Restricted stock compensation intended to align interests with shareholders was also granted during the period, comprising 46,995 shares with a 30-year restriction period, and expenses of ¥205 million were disclosed for the period. - FY2022-Q2AdvancedAnnual report
「2021 Stock Options Date of resolution 14 July 2021 Number of stock acquisition rights (units) 2,112 Categories and number of grantees (people) Executive officers 8 Fellows 3 Number of shares underlying the stock acquisition rights (shares) 8,448 Exercise period for stock acquisition rights From 4 August 2021 To 3 August 2051」
As 2021 stock options, 2,112 stock acquisition rights and 8,448 underlying shares were granted to 8 executive officers and 3 fellows. The exercise period is from 4 August 2021 to 3 August 2051. - FY2021AdvancedAnnual report
「During the current consolidated fiscal year, 50,883 shares were granted under the restricted stock compensation plan. The restriction period is 30 years.」
Restricted stock compensation intended to align interests with shareholders was also granted during the period, comprising 50,883 shares with a 30-year restriction period, and expenses of ¥201 million were disclosed. - FY2021-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter are as follows. 2020 Stock Options Number of stock acquisition rights (units) 3,110 Categories and number of grantees (people) Executive officers 9 Fellows 3 Exercise period for stock acquisition rights From 6 August 2020 To 5 August 2050」
As 2020 stock options, 3,110 stock acquisition rights were granted to 9 executive officers and 3 fellows. The exercise period is from 6 August 2020 to 5 August 2050. - FY2020AdvancedAnnual report
「During the current consolidated fiscal year, 61,774 shares were granted under the restricted stock compensation plan. The restriction period is 30 years.」
Restricted stock compensation intended to align interests with shareholders was granted, comprising 61,774 shares with a 30-year restriction period, and expenses of ¥152 million were disclosed for the period. - FY2020-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter are as follows.」
Stock options resolved on 11 July 2019 were granted to 8 executive officers and 4 fellows, comprising 3,400 stock acquisition rights and 13,600 underlying shares, with an exercise period from 2 August 2019 to 1 August 2049, as disclosed. - FY2019First statedAnnual report
「Compensation for executive directors is structured with fixed compensation, performance-linked compensation (bonuses) and restricted stock, with each component representing approximately 50%, 30% and 20% of the total, respectively.」
A compensation structure combining fixed compensation, bonuses and restricted stock was introduced to enhance corporate value over the medium to long term, promote appropriate risk-taking by management and align interests with shareholders. The restriction period is 30 years or until a director retires, and clawback provisions have also been established for violations of laws and regulations and other matters.